Transparency Life Sciences
2011
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A
LATEST DEAL TYPE
$5M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of a technology based digital drug development platform designed to transform clinical trial design and execution. The company's platform combines crowdsourcing and mobile health technology to advance drug candidates through clinical trials with patient convenience, data relevance, efficiency and affordability, enabling clinical trial sponsors to achieve better results at lower cost.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
- 45 West 34th Street
- Suite 804
- New York, NY 10001
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Transparency Life Sciences’s full profile, request a free trial.
Transparency Life Sciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 15-Feb-2018 | $5M | 000 | 0000 | Completed | Generating Revenue |
| 2. Grant | 08-Sep-2014 | 00.00 | Completed | Startup | ||
| 1. Seed Round | 17-Jul-2011 | Completed | Startup |
Transparency Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Transparency Life Sciences Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ObvioHealth | Venture Capital-Backed | Orlando, FL | 00.000 | 0000000000 0 | 00.000 | |
| 0000000 00 | Venture Capital-Backed | Los Angeles, CA | 00000 | 00000000000 | 00000 | |
| 0000000 | Venture Capital-Backed | Palo Alto, CA | 00.000 | 00000000000 | ||
| 000000000 00000000 | Private Equity-Backed | Morrisville, NC | 000 | 00000 | 0000000 0000 | 00000 |
| 00000000 000000000 | Formerly VC-backed | New York, NY | 0000 | 00000 | 000000&0 | 00000 |
Transparency Life Sciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| New Ventures Funds | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Small Business Innovation Research | Government | 000 0000 | 000000 0 |
Transparency Life Sciences Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Tomasz Sablinski Ph.D | Chief Executive Officer, Board Member and Co-Founder | ||
| Marc Foster | Chief Operating Officer, Board Member and Co-Founder | ||
| Scott Becker | Advisor |
Transparency Life Sciences Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Harry Glorikian | New Ventures Funds | Board Member | 000 0000 | |
| John Watson | Self | Board Member | 000 0000 | |
| Lawrence Steinman MD | Self | Scientific Advisory Board Chairman | 000 0000 | |
| Marc Foster | Transparency Life Sciences | Chief Operating Officer, Board Member and Co-Founder | 000 0000 | |
| Richard Warburg Ph.D | New Ventures Funds | Board Member & Advisor | 000 0000 |